Client Projects (Cell & Gene Therapeutics)
Oncology, Genetic Disorders, etc.
Preclinical through CommercialActive
Key Facts
Indication
Oncology, Genetic Disorders, etc.
Phase
Preclinical through Commercial
Status
Active
Company
About IDT Biologika
IDT Biologika is a century-old, privately-held German CDMO with a strong focus on complex biologics, particularly live virus products and viral vectors. It operates as a full-service partner offering end-to-end solutions from process development to commercial-scale drug substance manufacturing and aseptic fill-finish across two BSL-2 certified sites. With significant regulatory approvals (EMA, FDA) and over €600 million invested in its facilities since 1993, the company is positioned as a key player in the growing outsourced manufacturing market for vaccines and advanced therapies. Its deep historical expertise in virology provides a distinct competitive advantage in the cell and gene therapy space.
View full company profile